Corporate

Laccure has developed a novel, non-prescription, antibiotic-free vaginal pessary for one-time treatment of bacterial vaginosis

About the company

Laccure AB was founded in 2007 and is a project company within the group of the Swedish life science company AQILION AB. Both companies are privately owned and based in Helsingborg, Sweden. Aqilion scouts and unlocks life science potential.

To learn more, please visit:

AQILION

Company highlights

2007: Patent application for the use of the substance for treatment and prevention of gynecological infections

2010: GMP manufacturing for clinical trials completed

2011: Preclinical study results showed no vaginal irritation

2011: Completion of international survey in 2,660 women in the U.S, the U.K. and Germany

2012: Patent application for the protection of the formulation and manufacturing of Laccure’s product

2012: Completion of the upscaled commercial manufacturing of the substance to be used in Laccure’s vaginal pessary

2012: Completion of clinical trials with excellent results

2014: Final completion of preclinical study package. Results showed no cytotoxicity, sensitization or vaginal irritation

2015: Excellent clinical data on Laccure’s vaginal pessary were presented at XXI FIGO World Congress on Gyn & Obstetrics in Vancouver, Canada

2015: Laccure announced that its antibiotic-free consumer health product for bacterial vaginosis was ready for commercialization

2016: Laccure AB entered into a collaboration with Recipharm AB, a Swedish global leading contract development and manufacturing organization, for the commercial manufacturing and delivery of Laccure® pessary

2017: Laccure AB and Combe Inc. signed an exclusive global license agreement to Laccure’s new female consumer health product for treatment of bacterial vaginosis

2019: Combe Inc., announced the termination of the license agreement with Laccure AB since Combe changed its priorities and strategy for its development projects. Laccure took the product back and continued to pursue development toward commercialization with support from AQILION AB, one of the major owners and co-founder of Laccure

2019: Decision to test a new manufacturing method with the aim to receive a robust method resulting in more attractive costs

2020: Successful completion of small-scale manufacturing method

Laccure AB

Corporate Identity Number 556725-2076

Contact

E-mail: info@aqilion.com
By contacting us, you accept our privacy policy.

Visiting and postal address

Kullagatan 8, SE-252 20 Helsingborg, Sweden